Literature DB >> 8195047

Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2- aminothiazol-4-yl)-3-(substituted)-2-propenoylamino]-3-cephems with C-3 substitutions.

K Ishikura1, T Kubota, K Minami, Y Hamashima, H Nakashimizu, K Motokawa, Y Kimura, H Miwa, T Yoshida.   

Abstract

Synthesis and biological activity of a series of 7 beta-[(Z)-2-(2- aminothiazol-4-yl)-3-(substituted)-2-propenoylamino]-3-cephe m-4-carboxylic acids with C-3 substitutions and their pivaloyloxymethyl esters are described. These acid compounds exhibited potent antibacterial activity against both Gram-positive and Gram-negative bacteria. Pivaloyloxymethyl esters of selected compounds in this series were found to be well absorbed from small intestine in mice. Pivaloyloxymethyl 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-pentenoylamino]-3- carbamoyloxymethyl-3-cephem-4-carboxylase hydrochloride hydrate (S-1108) was finally selected as the candidate for clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195047     DOI: 10.7164/antibiotics.47.466

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dogs.

Authors:  K Mizojiri; S Futaguchi; R Norikura; Y Katsuyama; T Nagasaki; T Yoshimori; M Nakanishi
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

2.  Determination of cefcapene acid by LC-MS and their application to a pharmacokinetic study in healthy Chinese volunteers.

Authors:  Hong-Fei Duan; Li Ding; Xiao-Bing Li; Lin-Lin Hu; Ai-Dong Wen; Ye Leng; Zhen Liu
Journal:  J Pharm Anal       Date:  2012-10-07

3.  Synthesis and preliminary antimicrobial activities of new arylideneamino-1,3,4-thiadiazole-(thio/dithio)-acetamido cephalosporanic acids.

Authors:  Shakir Mahmood Alwan
Journal:  Molecules       Date:  2012-01-19       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.